Soligenix (SNGX) EBITDA Margin (2010 - 2024)
Soligenix's EBITDA Margin came in at -7902.83% for FY2024, down 6986.49 percentage points from -916.34% in FY2023.
Analysis
Soligenix (SNGX) EBITDA Margin (2010 - 2024) Analysis & Trends
Going back to FY2010, Soligenix's EBITDA Margin data covers 15 years.
- EBITDA Margin carries a five-year change of -7676.33 percentage points (FY2019 to FY2024).
- The FY2024 figure represents the lowest annual EBITDA Margin in data going back to FY2010.
- Per Business Quant, earlier years put EBITDA Margin at -916.34% in FY2023 (+581.62 pp), -1497.96% in FY2022 (+87.05 pp), -1585.02% in FY2021 (-799.91 pp) and -785.10% in FY2020 (-558.61 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Soligenix | 5.90 Mn | 5.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -74,427.28% |
| Mar 31, 2024 | -1,807.67% |
| Dec 31, 2023 | -872.62% |
| Sep 30, 2023 | -1,362.67% |
| Jun 30, 2023 | -787.10% |
| Mar 31, 2023 | -835.57% |
| Dec 31, 2022 | -974.40% |
| Sep 30, 2022 | -1,851.72% |
| Jun 30, 2022 | -1,481.27% |
| Mar 31, 2022 | -2,224.87% |
| Dec 31, 2021 | -1,634.02% |
| Sep 30, 2021 | -1,802.40% |
| Jun 30, 2021 | -1,387.10% |
| Mar 31, 2021 | -1,507.33% |
| Dec 31, 2020 | -1,707.12% |
| Sep 30, 2020 | -294.93% |
| Jun 30, 2020 | -553.36% |
| Mar 31, 2020 | -914.62% |
| Dec 31, 2019 | -480.53% |
| Sep 30, 2019 | -219.28% |
API Access
Soligenix EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SNGX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "SNGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SNGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();